ECSDI045123S - - Google Patents

Info

Publication number
ECSDI045123S
ECSDI045123S EC2004005123F ECSDI045123F ECSDI045123S EC SDI045123 S ECSDI045123 S EC SDI045123S EC 2004005123 F EC2004005123 F EC 2004005123F EC SDI045123 F ECSDI045123 F EC SDI045123F EC SDI045123 S ECSDI045123 S EC SDI045123S
Authority
EC
Ecuador
Application number
EC2004005123F
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSDI045123S publication Critical patent/ECSDI045123S/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
EC2004005123F 2001-11-26 2004-05-26 ECSDI045123S (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
ECSDI045123S true ECSDI045123S (en:Method) 2004-07-23

Family

ID=23302492

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2004005123F ECSDI045123S (en:Method) 2001-11-26 2004-05-26
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Country Status (28)

Country Link
US (3) US20030206906A1 (en:Method)
EP (1) EP1455858A4 (en:Method)
JP (1) JP4458240B2 (en:Method)
KR (2) KR20040054803A (en:Method)
CN (1) CN100478027C (en:Method)
AR (1) AR037437A1 (en:Method)
AU (2) AU2002365408B2 (en:Method)
BR (1) BR0215098A (en:Method)
CA (1) CA2467645C (en:Method)
CO (1) CO5580795A2 (en:Method)
EA (1) EA007594B1 (en:Method)
EC (2) ECSDI045123S (en:Method)
HR (1) HRP20040502A2 (en:Method)
HU (1) HUP0600436A3 (en:Method)
IL (2) IL162083A0 (en:Method)
IS (1) IS7275A (en:Method)
ME (1) ME00015B (en:Method)
MX (1) MXPA04004948A (en:Method)
MY (1) MY140404A (en:Method)
NO (1) NO331700B1 (en:Method)
NZ (1) NZ533029A (en:Method)
PL (1) PL371760A1 (en:Method)
RS (1) RS46204A (en:Method)
TW (1) TWI262794B (en:Method)
UA (1) UA81235C2 (en:Method)
UY (1) UY27550A1 (en:Method)
WO (1) WO2003045466A2 (en:Method)
ZA (1) ZA200404024B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533029A (en) 2001-11-26 2006-05-26 Genentech Inc Composition useful for removal of fibrin-bound blood clot from a catheter comprises water, a plasminogen activator and an alcohol
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
JP5566105B2 (ja) * 2006-08-28 2014-08-06 オムニオ・ヒーラー・アクチボラゲット 感染症に対する候補薬
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
EP2160152B1 (en) 2007-06-01 2016-07-27 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
WO2009033039A2 (en) * 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
US10456570B2 (en) 2015-06-11 2019-10-29 Proviflo, Llc Graft-port hemodialysis systems, devices, and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484A7 (fi) * 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
AU7998091A (en) * 1990-05-17 1991-12-10 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
WO1993024635A1 (en) * 1992-06-03 1993-12-09 Genentech, Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
EP0970950A3 (en) 1993-11-24 2000-04-05 DuPont Pharmaceuticals Company Novel isoxazoline and isoxazole fibrinogen receptor antagonists
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
WO2000053264A1 (en) 1999-03-11 2000-09-14 Du Pont Pharmaceuticals Company Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
US6346517B1 (en) * 1999-03-11 2002-02-12 Bristol-Myers Squibb Pharma Company Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
DE60133893D1 (de) 2000-05-10 2008-06-19 Ash Access Technology Inc Kathetersperrlösung mit photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
NZ533029A (en) * 2001-11-26 2006-05-26 Genentech Inc Composition useful for removal of fibrin-bound blood clot from a catheter comprises water, a plasminogen activator and an alcohol
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
ES2282529T3 (es) 2003-02-03 2007-10-16 Hans-Dietrich Dr.Techn. Polaschegg Composicion para la prevencion de una infeccion debida a un dispositi vo permanente.
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Also Published As

Publication number Publication date
ZA200404024B (en) 2005-07-27
EP1455858A4 (en) 2006-02-15
PL371760A1 (en) 2005-06-27
JP2005510302A (ja) 2005-04-21
AU2008203131A1 (en) 2008-08-07
CO5580795A2 (es) 2005-11-30
US7829082B2 (en) 2010-11-09
AU2002365408B2 (en) 2008-04-24
KR20100102745A (ko) 2010-09-24
ME00015B (me) 2010-06-10
UY27550A1 (es) 2003-06-30
UA81235C2 (en) 2007-12-25
NO331700B1 (no) 2012-02-27
CA2467645C (en) 2017-01-17
IS7275A (is) 2004-05-21
HUP0600436A2 (en) 2006-09-28
NZ533029A (en) 2006-05-26
BR0215098A (pt) 2004-12-14
MY140404A (en) 2009-12-31
CN1617738A (zh) 2005-05-18
WO2003045466A2 (en) 2003-06-05
KR20040054803A (ko) 2004-06-25
IL162083A (en) 2012-12-31
US20060257390A1 (en) 2006-11-16
AR037437A1 (es) 2004-11-10
MXPA04004948A (es) 2004-08-11
NO20042693L (no) 2004-08-25
WO2003045466A3 (en) 2003-10-09
HRP20040502A2 (en) 2004-12-31
CA2467645A1 (en) 2003-06-05
EA007594B1 (ru) 2006-12-29
TWI262794B (en) 2006-10-01
HUP0600436A3 (en) 2010-12-28
EA200400712A1 (ru) 2005-06-30
AU2002365408A1 (en) 2003-06-10
TW200303743A (en) 2003-09-16
JP4458240B2 (ja) 2010-04-28
ECSP045123A (es) 2004-07-23
CN100478027C (zh) 2009-04-15
US20060246050A1 (en) 2006-11-02
MEP8008A (xx) 2010-02-10
EP1455858A2 (en) 2004-09-15
US20030206906A1 (en) 2003-11-06
IL162083A0 (en) 2005-11-20
RS46204A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
BE2022C502I2 (en:Method)
BE2014C026I2 (en:Method)
BE2014C004I2 (en:Method)
BE2012C020I2 (en:Method)
BE2011C034I2 (en:Method)
BE2007C047I2 (en:Method)
AU2002307149A8 (en:Method)
BE2014C006I2 (en:Method)
JP2002168661A5 (en:Method)
JP2002245775A5 (en:Method)
BRPI0204884B1 (en:Method)
BE2014C008I2 (en:Method)
JP2001225819A5 (en:Method)
JP2002031931A5 (en:Method)
JP2002236419A5 (en:Method)
BRPI0210463A2 (en:Method)
AU2000280389A8 (en:Method)
JP2002056487A5 (en:Method)
JP2002206566A5 (en:Method)
JP2002229704A5 (en:Method)
JP2002207158A5 (en:Method)
JP2002108313A5 (en:Method)
BRMU8103221U (en:Method)
JP2002077901A5 (en:Method)
FR2806949A3 (en:Method)